[go: up one dir, main page]

AU2001266648A1 - Kits and methods for optimizing the efficacy of chondroprotective compositions - Google Patents

Kits and methods for optimizing the efficacy of chondroprotective compositions

Info

Publication number
AU2001266648A1
AU2001266648A1 AU2001266648A AU6664801A AU2001266648A1 AU 2001266648 A1 AU2001266648 A1 AU 2001266648A1 AU 2001266648 A AU2001266648 A AU 2001266648A AU 6664801 A AU6664801 A AU 6664801A AU 2001266648 A1 AU2001266648 A1 AU 2001266648A1
Authority
AU
Australia
Prior art keywords
kits
optimizing
efficacy
methods
chondroprotective compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001266648A
Inventor
Judith Lynn Harris
Robert Joseph Sarama
Kris Eugene Spence
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of AU2001266648A1 publication Critical patent/AU2001266648A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001266648A 2000-06-02 2001-06-01 Kits and methods for optimizing the efficacy of chondroprotective compositions Abandoned AU2001266648A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58651400A 2000-06-02 2000-06-02
US09586514 2000-06-02
PCT/US2001/017721 WO2001093833A2 (en) 2000-06-02 2001-06-01 Kits and methods for optimizing the efficacy of chondroprotective compositions

Publications (1)

Publication Number Publication Date
AU2001266648A1 true AU2001266648A1 (en) 2001-12-17

Family

ID=24346049

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001266648A Abandoned AU2001266648A1 (en) 2000-06-02 2001-06-01 Kits and methods for optimizing the efficacy of chondroprotective compositions

Country Status (8)

Country Link
EP (1) EP1289531A2 (en)
JP (1) JP2003535121A (en)
CN (1) CN1431908A (en)
AU (1) AU2001266648A1 (en)
BR (1) BR0111378A (en)
CA (1) CA2408611A1 (en)
MX (1) MXPA02011940A (en)
WO (1) WO2001093833A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003339318A (en) * 2002-05-28 2003-12-02 Sanei Gen Ffi Inc Tea drink stable in long period preservation and method for producing the same
JP4143387B2 (en) * 2002-11-21 2008-09-03 株式会社アセロラフーズ healthy food
AU2003903037A0 (en) 2003-06-17 2003-07-03 Institute Of Nutraceutical Research Connective tissue derived polypeptides
EP1838165A4 (en) * 2004-12-30 2012-01-18 Hills Pet Nutrition Inc Methods for enhancing the palatability of compositions for consumption by animals
GB2438574B (en) * 2005-03-14 2011-01-26 Sapporo Holdings Ltd Nutritionally balanced food or beverage product
WO2006130738A2 (en) * 2005-06-01 2006-12-07 Hill's Pet Nutrition, Inc. Methods for enhancing palatability of compositions for animal consumption
US8956677B2 (en) 2005-11-23 2015-02-17 The Coca-Cola Company High-potency sweetener composition with glucosamine and compositions sweetened therewith
CN116196319B (en) * 2021-11-30 2024-06-04 内蒙古伊利实业集团股份有限公司 Use of oligosaccharides for protecting cartilage

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2103387C3 (en) * 1971-01-26 1982-05-06 Johann G.W. Opfermann & Sohn, 5070 Bergisch-Gladbach Use of the hydrochloride of glucosamine for the manufacture of pharmaceutical preparations
US4766209A (en) * 1986-03-10 1988-08-23 Nestec S. A. Amino sugar carbonating agents and their preparation
JP3693359B2 (en) * 1993-07-21 2005-09-07 マルハ株式会社 Bone strengthening promoter
IT1270095B (en) * 1994-09-28 1997-04-28 Ibsa Inst Biochimique Sa THERAPEUTIC COMPOSITIONS OF CHONDROITIN SULPHATE IN THE FORM OF ORAL ADMINISTRABLE GEL
US5843919A (en) * 1996-11-25 1998-12-01 Burger; John A. Composition and method for the treatment of arthritis
AU6141498A (en) * 1997-02-04 1998-08-25 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
AU6954598A (en) * 1997-04-10 1998-10-30 Richardson Labs, Inc. Composition comprising a hydrolysed collagen protein and glucosamine for the treatment of arthroses
US6391864B1 (en) * 1998-08-19 2002-05-21 Joint Juice, Inc. Food supplement containing a cartilage supplement
JP2000166467A (en) * 1998-12-10 2000-06-20 Nippon Kefia Kk Health food containing fermented milk product and herbs
ZA9811635B (en) * 1998-12-18 1999-07-28 Gerard Finn Glucosamine hydrochloride drink
DE19859771C1 (en) * 1998-12-23 2000-08-24 Sueddeutsche Kalkstickstoff Water-soluble, stable pyruvic acid (salt) -containing formulation
JP4173606B2 (en) * 1999-06-18 2008-10-29 サントリー株式会社 Method for producing low acid beverage
JP4249853B2 (en) * 1999-08-09 2009-04-08 焼津水産化学工業株式会社 Oral skin moisturizer

Also Published As

Publication number Publication date
CA2408611A1 (en) 2001-12-13
BR0111378A (en) 2003-06-17
MXPA02011940A (en) 2003-04-22
EP1289531A2 (en) 2003-03-12
WO2001093833A2 (en) 2001-12-13
WO2001093833A3 (en) 2002-04-25
JP2003535121A (en) 2003-11-25
CN1431908A (en) 2003-07-23

Similar Documents

Publication Publication Date Title
AU2002357119A1 (en) Mitocidal compositions and methods
AU2001245437A1 (en) Lightweight methods and compositions for well treating
AU2001280968A1 (en) Compositions and methods for directed gene assembly
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
AU2002361623A1 (en) Methods and compositions for chromatography
AU2001280599A1 (en) Compounds and methods
AU2001253418A1 (en) Compounds and methods
AU2001245987A1 (en) Compositions and methods for gene therapy
AU2002364708A1 (en) Novel compositions and methods for cancer
AU2001286750A1 (en) Compositions and methods for exon profiling
AU2001243394A1 (en) Compounds and methods
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU2001247282A1 (en) Lightweight methods and compositions for sand control
AUPQ872300A0 (en) Compounds and methods
AU2001266648A1 (en) Kits and methods for optimizing the efficacy of chondroprotective compositions
AU2001283226A1 (en) Methods and compositions for inhibiting rad51
AU2002366809A1 (en) Syn3 compositions and methods
AU2002239739A1 (en) Compositions, methods and kits relating to remodelin
AU2001278951A1 (en) Compounds and methods
AU2002337943A1 (en) Novel compositions and methods for cancer
AU2001261317A1 (en) Immunostimulant compositions and associated methods
AU2001235764A1 (en) Compositions
AU2002235277A1 (en) Compounds and methods
AU5243899A (en) Methods and compositions for using moclobemide
AU2001262163A1 (en) Composition